Commentary to: “The use of high-dose Omega-3 PUFAs and Vitamin-D co-supplementation as a therapeutic approach for IBD-related symptoms: case report and literature review”

by L. Laterza, A. Gasbarrini
Published 2019-08-01

Colonic disease and the microbiota

by F. Franceschi, M. De Siena, A. Gasbarrini
Published 2020-07-01

Benefits of multistrain bacteria formulations for health

by L. Laterza, G. Gibiino, F. Scaldaferri, A. Gasbarrini
Published 2018-08-01

The impact of oral microbiota on systemic and oral health: a literature review of recently published papers

by R. Patini, F. Franceschi, E. Staderini, A. Gasbarrini
Published 2020-06-01

Humans and microbiota: an unbreakable bond

by F. Franceschi, H. Tilg, F. Megraud, A. Gasbarrini
Published 2019-07-01

Microbiome in GI cancer

by F. Franceschi, M. De Siena, G. Gibiino, A. Gasbarrini
Published 2020-01-01

Proteobacteria: A Common Factor in Human Diseases

by G. Rizzatti, L. R. Lopetuso, G. Gibiino, C. Binda, A. Gasbarrini
Published 2017-01-01

The oral microbiota in oral and systemic diseases

by M. Cintoni, E. Rinninella, F. Scaldaferri, G. Ianiro, F. Franceschi, M. Mele, A. Gasbarrini
Published 2020-01-01

Pre- and Posttherapy Assessment of Intestinal Soluble Mediators in IBD: Where We Stand and Future Perspectives

by F. Scaldaferri, V. Petito, L. Lopetuso, G. Bruno, V. Gerardi, G. Ianiro, A. Sgambato, A. Gasbarrini, G. Cammarota
Published 2013-01-01

Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders

by D. Pagliari, A. Saviano, E. E. Newton, M. L. Serricchio, A. A. Dal Lago, A. Gasbarrini, R. Cianci
Published 2018-01-01

The role of rifaximin in irritable bowel syndrome derived from a network meta-analysis of randomized control trials

by T. Rokkas, Y. Niv, J. Gisbert, F. Franceschi, A. Gasbarrini, G. Hold, C. O'Morain, P. Malfertheiner, F. Megraud
Published 2020-07-01

Small Intestinal Bacterial Overgrowth Affects the Responsiveness to Colchicine in Familial Mediterranean Fever

by E. Verrecchia, L. L. Sicignano, M. La Regina, G. Nucera, I. Patisso, L. Cerrito, M. Montalto, A. Gasbarrini, R. Manna
Published 2017-01-01

Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report

by C. Caruso, S. Colantuono, D. Pugliese, C. Di Mario, B. Tolusso, E. Gremese, G. Papparella, F. Castrì, A. Gasbarrini, A. Romano, A. Armuzzi
Published 2020-04-01

Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients

by A. Poscia, J. Stojanovic, F. Kheiraoui, E. M. Proli, F. Scaldaferri, M. Volpe, M. L. Di Pietro, A. Gasbarrini, L. Fabrizio, S. Boccia, C. Favaretti
Published 2017-01-01

Correction to: Recurrent pregnancy loss is associated to leaky gut: a novel pathogenic model of endometrium inflammation?

by C. Tersigni, S. D’Ippolito, F. Di Nicuolo, R. Marana, V. Valenza, V. Masciullo, F. Scaldaferri, F. Malatacca, C. de Waure, A. Gasbarrini, G. Scambia, N. Di Simone
Published 2019-03-01

Recurrent pregnancy loss is associated to leaky gut: a novel pathogenic model of endometrium inflammation?

by C. Tersigni, S. D’Ippolito, F. Di Nicuolo, R. Marana, V. Valenza, V. Masciullo, F. Scaldaferri, F. Malatacca, C. de Waure, A. Gasbarrini, G. Scambia, N. Di Simone
Published 2018-04-01

Comparison of the impact of Helicobacter pylori eradication treatment with bismuth and non-bismuth quadruple regimens on the gut microbiota

by S. Prast-Nielsen, A. McNicholl, C. O’Morain, F. Megraud, J. Machado, T. Alarcon, M. Leja, A. Gasbarrini, L. Andersen, L. Engstrand, J. Gisbert, on behalf European Helicobacter and Microbiota Study Group (EHMSG; www.helicobacter.org)
Published 2019-11-01

Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide

by F. Scaldaferri, M. Pizzoferrato, L. R. Lopetuso, T. Musca, F. Ingravalle, L. L. Sicignano, M. Mentella, G. Miggiano, M. C. Mele, E. Gaetani, C. Graziani, V. Petito, G. Cammarota, E. Marzetti, A. Martone, F. Landi, A. Gasbarrini
Published 2017-01-01